Guardian Pharmacy Services (GRDN) Cost of Revenue (2023 - 2026)

Guardian Pharmacy Services (GRDN) has 4 years of Cost of Revenue data on file, last reported at $260.3 million in Q1 2026.

• Quarterly Cost of Revenue fell 1.76% year-over-year to $260.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 billion (up 11.92% YoY) and the FY2025 annual result came in at $1.2 billion, up 17.47% from the prior year.
• Cost of Revenue fell to $260.3 million in Q1 2026 per GRDN's latest filing, from $312.1 million in the prior quarter.
• The five-year high for Cost of Revenue was $312.1 million in Q4 2025, with the low at $210.5 million in Q3 2023.
• Average Cost of Revenue over 4 years is $257.9 million, with a median of $260.3 million recorded in 2026.
• Year-over-year, Cost of Revenue rose 20.41% in 2024 and slipped 1.76% in 2026.
• Guardian Pharmacy Services' Cost of Revenue stood at $226.5 million in 2023, then grew by 19.86% to $271.5 million in 2024, then rose by 14.97% to $312.1 million in 2025, then dropped by 16.61% to $260.3 million in 2026.
• Business Quant data shows GRDN's Cost of Revenue at $260.3 million in Q1 2026, $312.1 million in Q4 2025, and $302.7 million in Q3 2025.